CoChat

NUAK2 is a critical YAP target in liver cancer

Open access
Yuan, Wei-Chien, Pepe-Mooney, Brian, Galli, Giorgio G., Dill, Michael T., Huang, Hai-Tsang, Hao, Mingfeng, Wang, Yumeng, Liang, Han, Calogero, Raffaele A., Camargo, Fernando D. · 2018 · Nature Communications
Cited by 128

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

The Hippo-YAP signaling pathway is a critical regulator of proliferation, apoptosis, and cell fate. The main downstream effector of this pathway, YAP, has been shown to be misregulated in human cancer and has emerged as an attractive target for therapeutics. A significant insufficiency in our understanding of the pathway is the identity of transcriptional targets of YAP that drive its potent growth phenotypes. Here, using liver cancer as a model, we identify NUAK2 as an essential mediator of YAP-driven hepatomegaly and tumorigenesis in vivo. By evaluating several human cancer cell lines we determine that NUAK2 is selectively required for YAP-driven growth. Mechanistically, we found that NUAK2 participates in a feedback loop to maximize YAP activity via promotion of actin polymerization and myosin activity. Additionally, pharmacological inactivation of NUAK2 suppresses YAP-dependent cancer cell proliferation and liver overgrowth. Importantly, our work here identifies a specific, potent, and actionable target for YAP-driven malignancies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-07394-5

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 128

Metadata

Authors
Yuan, W.-C., Pepe-Mooney, B., Galli, G. G., Dill, M. T., Huang, H.-T., Hao, M., Wang, Y., Liang, H., Calogero, R. A., & Camargo, F. D.
Venue
Nature Communications
Published
2018-11-16
Volume
9
Issue
1
Pages
4834-4834
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2901482699
Cited by
128
References
18
FWCI
5.73
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NUAK2 is a critical YAP target in liver cancer. https://app.cochat.ai/papers/10.1038/s41467-018-07394-5
The paper
Yuan, W.-C., Pepe-Mooney, B., Galli, G. G., Dill, M. T., Huang, H.-T., Hao, M., Wang, Y., Liang, H., Calogero, R. A., & Camargo, F. D. (2018). NUAK2 is a critical YAP target in liver cancer. Nature Communications. https://doi.org/10.1038/s41467-018-07394-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.